Shopping Cart
- Remove All
- Your shopping cart is currently empty
Werner syndrome RecQ helicase-IN-4 is an effective inhibitor of Werner syndrome RecQ DNA helicase (WRN), exhibiting anticancer and antiproliferative activities, used for colorectal and gastric cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $333 | In Stock | |
5 mg | $790 | In Stock | |
10 mg | $1,120 | In Stock | |
25 mg | $1,670 | In Stock | |
50 mg | $2,180 | In Stock | |
100 mg | $2,800 | In Stock |
Description | Werner syndrome RecQ helicase-IN-4 is an effective inhibitor of Werner syndrome RecQ DNA helicase (WRN), exhibiting anticancer and antiproliferative activities, used for colorectal and gastric cancer research. |
Targets&IC50 | WRN:0.06 µM |
In vitro | Werner syndrome RecQ helicase-IN-4 is an inhibitor of RecQ DNA helicase (WRN) with an IC50 value of 0.06 µM. |
In vivo | Werner syndrome RecQ helicase-IN-4 (240 mg/kg, 18 days, orally) showed anticancer activity in SW48 xenografted mice. [1] |
Molecular Weight | 666.65 |
Formula | C32H33F3N8O5 |
Cas No. | 2869954-53-8 |
Smiles | O=C(C1=NC=CC=C1O)N2CCN(C=3C(=O)N4N=C(N=C4N(C3CC)CC(=O)NC5=CC=C(C=C5C)C(F)(F)F)C6=CCOCC6)CC2 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (120 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.